
VindaMax Capsule 61 mg (Tafamidis)
61mg
Soft capsule · Prescription medication
Pfizer Pharmaceuticals Korea Co., Ltd.
Tafamidis is a medication used to treat transthyretin amyloidosis.
MFDS ingredient code M279366
Tafamidis is a drug that helps stabilize the transthyretin protein and is used in the treatment of amyloidosis. This ingredient is effective against neurologic disorders and primarily aims to alleviate symptoms caused by transthyretin misfolding.
Tafamidis prevents the abnormal transformation of the transthyretin protein, thus halting the accumulation of amyloid. This reduces nerve damage and slows the progression of the disease.
Approved uses differ by product. Check each product's information for its actual use.
Tafamidis is a specialized medication for the treatment of amyloidosis, focusing on protein stabilization, unlike other cardiovascular drugs. As a result, it effectively improves neurological symptoms.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.